跳至主要内容
临床试验/ISRCTN67978523
ISRCTN67978523已完成未知

Effects of dietary nitrate and folate supplementation on blood pressure in hypertensive Tanzanians: a feasibility trial

Institute of Cellular Medicine, Newcastle University0 个研究点目标入组 47 人开始时间: 2018年11月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
47

研究概览

简要总结

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32729923/ results (added 03/08/2020) 2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/31872153/ Design and baseline characteristics (added 17/01/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 50-70 years old
  • 2. Non-smokers
  • 3. Drug naïve
  • 4. Hypertension (stage 1, systolic blood pressure 130-170 mmHg)
  • 5. BMI 18-40 kg/m²

排除标准

  • 1. Current participation in other clinical investigations
  • 2. Physical disabilities, trauma or surgery which limit mobility and affect participation to the trial
  • 3. Vegetarianism
  • 4. Aversion to beetroot consumption or inability to comply with the study diet
  • 5. Substantial weight change in the last 3 months
  • 6. Active cancer and any diagnosis of malignant cancer in the last 5 years
  • 7. Chronic and acute metabolic and inflammatory conditions interfering with the study outcome (e.g. history of severe liver disease, inflammatory bowel diseases or rheumatoid arthritis)
  • 8. Previous diagnosis of type 1 or type 2 diabetes treated with insulin
  • 9. Taking any drugs that have an effect on nitric oxide production or insulin sensitivity, including oral corticosteroids, sildenafil, anti-hypertensive (beta-blockers, calcium antagonists, ace-inhibitors and angiotensin receptors inhibitors), diuretics, laxatives, anticoagulants, nitrate derived agents and anti-cholinergics
  • 10. Taking hormonal therapies (oestrogens, thyroxine, progesterone, oral hypoglycaemic agents) if the dose has been started/changed in the previous 3 months
  • 11. Taking statins and any other anti-dyslipidaemic agent if the dose has been started/changed in the previous 3 months
  • 12. Taking psychiatric drugs (antidepressants, sedatives, antipsychotics) if the dose has been started/changed in the previous 3 months
  • 13. History of severe anaemia (Hb < 8mg/dL) (risk for the participant and effects on the study outcomes).
  • 14. Current diagnosis of severe infectious diseases (known HIV positive, malaria, hepatitis, yellow fever etc)
  • 15. Major surgical operations interfering with the study outcomes

研究者

发起方
Institute of Cellular Medicine, Newcastle University

相似试验